Trial Details

COMPLETED
Basic Information
Clinical ID c310
Identifier NCT06274996
Trial Title Efficacy and Safety Analysis of Upadacitinib in Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases
Interventions DRUG: Upadacitinib
Participant Information
Sponsor Sixth Affiliated Hospital, Sun Yat-sen University
City Guangzhou
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2021-01-01
Primary Completion Date 2023-12-31
Completion Date 2023-12-31